Everolimus Enhances Gemcitabine-Induced Cytotoxicity in Bladder-Cancer Cell Lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Everolimus Enhances Gemcitabine-Induced Cytotoxicity in Bladder-Cancer Cell Lines

Published:2012-07 Issue:13-15 Volume:75 Page:788-799
ISSN:1528-7394
Container-title:Journal of Toxicology and Environmental Health, Part A
language:en
Short-container-title:Journal of Toxicology and Environmental Health, Part A

Author:

Pinto-Leite Rosário,Arantes-Rodrigues Regina,Palmeira Carlos,Gaivão Isabel,Cardoso Maria Luís,Colaço Aura,Santos Lúcio,Oliveira Paula

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

http://www.tandfonline.com/doi/pdf/10.1080/15287394.2012.690325

Reference50 articles.

1. Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV

2. Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)

3. Antitumor Efficacy of Intermittent Treatment Schedules with the Rapamycin Derivative RAD001 Correlates with Prolonged Inactivation of Ribosomal Protein S6 Kinase 1 in Peripheral Blood Mononuclear Cells

4. mTORC1- and mTORC2-interacting proteins keep their multifunctional partners focused

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PRRX1/FOXM1 reduces gemcitabin-induced cytotoxicity by regulating autophagy in bladder cancer;Translational Andrology and Urology;2022-08

2. Novel intravesical therapeutics in the treatment of non-muscle invasive bladder cancer: Horizon scanning;Frontiers in Surgery;2022-07-26

3. Antiproliferative and apoptotic activity of gemcitabine-lauric acid conjugate on human bladder cancer cells;IRAN J BASIC MED SCI;2022

4. Gemcitabine Cooperates with Everolimus to Inhibit the Growth of and Sensitize Malignant Meningioma Cells to Apoptosis Induced by Navitoclax, an Inhibitor of Anti-Apoptotic BCL-2 Family Proteins;Cancers;2022-03-27

5. Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway;Oncology Reports;2021-12-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3